PYRIDAZIN-3-CARBOXAMIDE COMPOUND AS TYK2 INHIBITOR
The present invention provides a pyridazin-3-carboxamide compound of general formula (I), or a pharmaceutically acceptable salt, enantiomer, diastereomer, raceme, solvate, hydrate, polymorphic form, prodrug, or isotopic variant thereof. The present invention further provides a pharmaceutical composi...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
15.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a pyridazin-3-carboxamide compound of general formula (I), or a pharmaceutically acceptable salt, enantiomer, diastereomer, raceme, solvate, hydrate, polymorphic form, prodrug, or isotopic variant thereof. The present invention further provides a pharmaceutical composition comprising the compound, a preparation method for the pharmaceutical composition, and a use of the pharmaceutical composition in treatment or prevention of TYK2 kinase-mediated diseases. |
---|---|
Bibliography: | Application Number: AU20230283530 |